Abstract Lens opacity 13 (lop13) is a spontaneous, autosomal recessive mouse mutant that exhibits nuclear cataracts. Histological analysis revealed swollen lens fiber cells and the presence of bladder cells within the lens cortex, as well as morgagnian globules and liquefied material at the lens posterior. At 3 months of age, in addition to cataracts, lop13 mice also develop persistent skin wounds. Linkage analysis assigned the lop13 locus to a 1.1-Mb region on mouse Chr 15, encompassing 19 candidate genes. Sequence analysis identified a C3112T mutation in exon 18 of Sterol Regulatory Element BindingTranscription Factor 2 (Srebf2) resulting in the R1038C substitution of a highly conserved arginine within the Srebf2 regulatory domain. Srebf2 belongs to a family of membrane-bound basic helix-loop-helix leucine zipper transcription factors that control the expression of genes involved in the biosynthesis and uptake of cholesterol and fatty acids. The lack of complementation observed in Srebf2 lop13/GT compound heterozygotes carrying the Srebf2 gene trapped allele (Srebf2 GT ) provides genetic evidence that the identified C3112T substitution in Srebf2 is responsible for the lop13 phenotype. Gas chromatography analysis identified lower levels of cholesterol in the lop13 brain, liver, and lens when compared to wild-type mice. These findings suggest that lop13 is a hypomorphic mutation in Srebf2. As such, the lop13 mouse presents an invaluable in vivo model for studying the contribution of Srebf2 and cholesterol to maintaining the homeostasis of the lens and skin.
Introduction
Ocular lens transparency is essential for transmitting and focusing light onto the retina. Cataracts are defined as the loss of lens transparency and are considered clinically relevant if they significantly affect visual acuity. Although treatable with surgery, cataracts remain the leading cause of blindness worldwide, affecting approximately 18 million people (Foster and Resnikoff 2005) . Age-related cataracts are the most common form of cataracts, in which the onset is after the age of 40 (Congdon et al. 2004) . As a result of population growth and aging worldwide, it has been predicted that by 2020 the number of individuals affected with cataracts would double from that observed in 2004 (Resnikoff et al. 2004) .
The development of age-related cataracts has been associated with environmental factors such as exposure to UV light, smoking, diabetes, myopia, nutrition, obesity, HDL cholesterol levels, and corticosteroid use (Abraham et al. 2006; DeBlack 2003; Hodge et al. 1995; Taylor 1999; West and Valmadrid 1995) . In addition, twin studies established a significant genetic component contributing to age-related cataracts (Hammond et al. 2000 (Hammond et al. , 2001a . It has been postulated that as many as 40 genes might be involved in cataract formation (Hejtmancik and Kantorow 2004) . Allelic variations in EPHA2, GJA8, GALT, SLC16A12, HSF4, GALK1, FTL, and CRYAA have been associated with the formation of age-related cataracts in some populations (Bhagyalaxmi et al. 2009; Faniello et al. 2009; Jun et al. 2009; Karas et al. 2003; Liu et al. 2011; Okano et al. 2001; Shi et al. 2008; Shiels et al. 2008 Shiels et al. , 2010 Zuercher et al. 2010) . However, the identified variations in these genes contribute to only a small proportion of all cases of age-related cataracts.
Congenital cataracts, although only a small portion of all cataract cases, have contributed a great deal to our knowledge about the molecular etiology of cataracts (Francis and Moore 2004; Graw 2004) . To date, at least 39 cataract loci have been mapped and mutations have been identified in 26 genes (Hejtmancik 2008; Shiels et al. 2010; Shiels and Hejtmancik 2007) . The genes and mutations associated with Mendelian forms of congenital cataracts have been recently reviewed (Hejtmancik 2008; Shiels and Hejtmancik 2007) . The majority of mutations were identified in crystallins, a family of abundantly expressed structural proteins that are essential for transparency of the lens. In addition, mutations in gap junction proteins, lens membrane proteins, beaded filament structural proteins, and transcription factors have also been identified as contributing to Mendelian forms of congenital cataracts (Hejtmancik 2008) . Although great progress has been made, the genetic basis of numerous Mendelian cataract loci remains unknown. At least 16 orphan cataract loci have been mapped onto a chromosome where the underlying genes and mutations remain unknown (Shiels et al. 2010) .
Although congenital cataracts often occur as an isolated defect, the loss of lens transparency has been associated with syndromic diseases presenting clinically with additional ocular defects or with other systemic abnormalities. Congenital cataracts associated with syndromes that include only ocular defects often occur with varying defects of the anterior segment, optic nerve, retina, and vitreous body. Mutations in the transcription factors FOXE3, PAX6, PITX3, MAF, and VSX2 have been associated with ocular syndromes that include cataracts, microphthalmia, secondary glaucoma, and anterior segment defects (Gould and John 2002; Shiels et al. 2010) . Congenital cataracts have also been associated with severe systemic disorders, including neurologic and metabolic disorders, with abnormalities of numerous organs. These syndromic cataracts are known to be caused by various genetic defects, including single-gene defects, chromosomal abnormalities, triplet repeat disorders, and mitochondrial gene defects (Shiels et al. 2010) . However, as with age-related and congenital cataracts, numerous genes associated with syndromic cataracts remain unknown.
In our quest for the identification of novel genes essential for lens transparency, we evaluated the lens opacity 13 (lop13) mouse, a spontaneous autosomal recessive mutation previously reported to exhibit nuclear cataracts between 3 and 4 weeks of age (Varnum 1981) . In addition to cataracts, we show that lop13 mice develop previously unreported persistent skin wounds. The initial linkage analysis assigned the lop13 locus to mouse Chr 15 (Chang et al. 2005) . The results from our study show that a mutation in the sterol regulatory element binding transcription factor 2 (Srebf2) gene is responsible for the lop13 phenotype. The role of Srebf2 has been previously established as a transcriptional regulator of genes involved in de novo cholesterol biosynthesis and of genes associated with endocytic cholesterol uptake (Horton et al. 2002) . The role of Srebf2 during the development and/or homeostasis of the lens and skin had never been evaluated.
Materials and methods

Mice
The lop13 and C3A.BLiA-Pde6b?/J mice were obtained from the Jackson Laboratory. C3A.BLiA-Pde6b?/J is a Pde6b(?) strain of C3H/HeJ (http://jaxmice.jax.org/strain/ 001912.html). Both C3A.BLiA-Pde6b?/J and lop13 strains exhibited normal breeding patterns. The Srebf2 gene trap (GT) mouse was generated from a trapped embryonic stem (ES) cell line YTA054 (EI183084.1) (Stryke et al. 2003) . The mutant allele was designated as Srebf2
GT . The YTA054 cells were injected into blastocysts from C57BL/ 6J mice and implanted into pseudopregnant C57/BL6 females. Germline transmission was indicated by coat color, and heterozygote mutant animals were identified by PCR genotyping. The chimeric males were outcrossed to C57BL/6J females and progeny were genotyped for the presence of the trapped allele. Srebf2
GT/? mice were maintained on 129P2/OlaHsd and C57BL/6J mixed backgrounds. Srebf2
GT/? to Srebf2 GT/? breedings generated 51 mice from nine litters and the progeny were genotyped. For complementation studies, Srebf2
GT/? to lop13/lop13 breedings generated 37 mice from 12 litters and the progeny were genotyped. Mendelian segregation for all breedings was evaluated using the v 2 test.
PCR genotyping
Two-millimeter tail clippings were collected and DNA was purified by boiling the tail sample with 50 mM NaOH, neutralizing the reaction with 1 M Tris (pH 8.0), and centrifuging the sample. Initially, PCR was carried out under the following conditions: 94°C for 3 min; 30 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 30 s; in addition to 7 min at 72°C using the primers TTA TCG ATG AGC GTG GTG GTT ATG C and GCG CGT ACA TCG GGC AAA TAA TAT C that annealed in the b-galactosidase gene within the pGT0Lxf gene trap vector.
To determine the exact genomic site of the trap insertion, we utilized long-range PCR (LR-PCR) with the primers TTC CAA GGA TCA GCT CAG GTC AC and TCT TTG AGC ACC AGA GGA CAT CC using the LR-PCR kit (Qiagen, Valencia, CA) following the manufacturer's protocol. The PCR conditions were 93°C for 3 min and 35 cycles of 93°C for 15 s, 62°C for 30 s, and 68°C for 5 min. PCR products were electrophoresed, gel-purified, and sequenced as described previously (Talamas et al. 2006) . Once the pGT0Lxf insertion site was cloned, genotyping of the wild-type Srebf2 and Srebf2 GT allele was performed using the same forward primer ATC TAA CTG GTC CCC TGG AGC AC and the reverse primer TGG GGA GGG AAT GAA GTA CTG ACT to amplify Srebf2 intron 1 of the wild-type allele or the reverse primer CAT ACA GTC CTC TTC ACA TCC ATG C to amplify the region of Srebf2 intron 1 harboring the gene trap.
Clinical evaluation and histology
For clinical evaluation, mouse eyes were dilated with 1% atropine sulfate (Bausch & Lomb) and examined with a Topcon SL-D8Z slit lamp biomicroscope with a Nikon SLR-based Photo Slit Lamp imaging system. For histological analysis, eyes from 8-week-old animals were fixed in zinc-formalin, or Davidson's solution, embedded in paraffin, and sectioned to 4-lm thickness as previously described (Hassemer et al. 2010) . Skin wounds were imaged with a RetCam II (Clarity Medical Systems, Pleasanton, CA). Skin samples from mouse backs and whole eye globes containing the eyelids were collected from wild-type and lop13 mice and fixed in Davidson's solution, embedded in paraffin, and sectioned to 4-lm thickness. Following H&E staining, sections were mounted and photographed with a Nikon DS-Fi1 camera on a Nikon Eclipse 80i microscope.
Linkage analysis
The lop13 locus has been maintained on the congenic 129/ sv-ter background. For linkage studies, lop13 mice were outcrossed to C3A.BLiA-Pde6b?/J. The resulting F1 progeny were backcrossed to lop13 mice to generate 326 F2 progeny. At 4 weeks of age, F2 progeny were clinically evaluated for the presence of cataracts as described above. Following phenotyping, F2 progeny were euthanized and tissues were collected. Genomic DNA was purified from collected tissues as previously described (Talamas et al. 2006) . Initially, 25 F2 progeny were genotyped as previously described (Talamas et al. 2006 ) with polymorphic microsatellites selected across Chr 15: D15Mit86, D15Mit209, D15Mit105, D15Mit29, D15Mit28, D15Mit260, D15Mit118, D15Mit33, D15Mit107, D15Mit108, D15Mit161, and D15Mit14. Microsatellite alleles were scored following electrophoresis. Linkage data were analyzed with MapManager QTX (http://www.mapmanager.org/mmQTX.html). An additional 119 progeny were mapped with D15Mit29, D15Mit28, D15Mit260, D15Mit118, D15Mit33, D15Mit107, D15Mit108, and D15Mit161 only. Further fine-mapping analysis was performed on an additional 182 F2 progeny using microsatellites D15Mit33 and D15Mit118. The chromosomal break points were further genotyped in the five recombinant animals with SNPs we identified in Csdc2 and Serhl, ss325997172 and ss32997173, respectively. The PCR conditions for ss325997172 were 95°C for 3 min; 30 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 30 s; and 72°C for 7 min using the primers GCT GGC TTC AAA CTG TCC TTT CA and GGT TGA AGG ACT GAG TGG GTG AC. The PCR conditions for ss32997173 were 95°C for 3 min; 30 cycles of 94°C for 30 s, 58°C for 30 s, 72°C for 30 s; and 72°C for 7 min using the primers CGC TAA AAC TGG GGC TAA GGA GA and ACT GAG GCA CAG GAA AGG GAG AA. The PCR products were electrophoresed, gel extracted, and sequenced as described previously (Talamas et al. 2006 ).
Candidate gene analysis
For the exon and intron/exon junction analysis, primers were designed to anneal 50 bp downstream from intron/ exon junctions and targets were PCR amplified from genomic DNA and sequenced as previously described for exon sequencing (Talamas et al. 2006) . For cDNA analysis and Srebf2 expression, RNA was purified from the spleens or eyes from wild-type and lop13/lop13 mice, reverse transcribed, and amplified as previously described (Talamas et al. 2006) . DNAStar software (DNASTAR, Inc., Madison, WI) was utilized for comparative analysis of the sequences. The list of primer sequences is summarized in supplementary material.
Cholesterol analysis
Livers (n = 7), brains (n = 8), and lenses (n = 4) from wild-type and lop13 mice were individually homogenized in a Dounce homogenizer in 1.0 ml of PBS. A 1:1:0.5 mixture of chloroform:methanol:water was utilized to extract the lipids. The organic phases were combined, washed once with 0.5 ml of KCl (1 M) followed by 0.5 ml of water, dried at 40°C under N 2 gas, and stored at -80°C. The cholesterol analysis was performed as previously described (Ryu et al. 2006) , with modifications. Briefly, an equivalent of 0.1 mg of lipid was used per sample. Cholesterol-d6 (4.366 nmol) (C/D/N Isotopes Inc., PointeClaire, QC, Canada) was added to each sample prior to derivatization. Each lipid extract was dried under nitrogen and redissolved in pyridine (70 ll), and the sample was derivatized by addition of a silylation reagent (30 ll) such as N-trimethylsilyl-N-methyltrifluoroacetamide with trimethylchlorosilane (MSTFA ? 1% TMCS) and incubated at 50°C for 1 h. GC-MS analysis of the silylated extracts was performed on an Agilent model 6890N GC coupled to an Agilent model 5975N quadrupole mass selective detector (MSD) (Agilent Technologies, Santa Clara, CA). Separation was achieved on a HP-5MS fused silica capillary column (5% phenyl methyl siloxane; column length = 60 m; internal diameter = 0.25 mm; film thickness = 0.25 lm). The GC operating conditions were as follows: initial temperature of 150°C, increased to 300°C at a rate of 25°C/min, then from 300 to 325°C at a rate of 3°C/min, with a final isothermal hold at 325°C for 5 min (total run duration = 19.33 min). Helium was used as the carrier gas at an initial flow of 1.0 ml/min. The samples (1 ll) were injected in a split mode with an Agilent 7683 autosampler. The temperature of the injector and the mass spectrometry transfer line was set at 280°C. The mass spectrometer was operated in the electron impact mode (EI) at 70 eV ionization energy, scanning for selective ions for each metabolite: cholesterol (m/z 368 and 458) and cholesterol-d6 (m/z 374 and 464). Data were acquired and processed using the Agilent Chemstation software AMDIS (www.amdis.net), and MET-IDEA (Broeckling et al. 2006) .
The serum cholesterol analysis was performed as previously described (Garber et al. 2000) . Briefly, wild-type (n = 4) and lop13 (n = 4) mice were fasted for 8 h prior to the blood draw. Blood was collected from the submandibular vein and serum was collected following centrifugation at 13,000 rpm for 10 min. Cholesterol levels were subsequently analyzed via FPLC using the Infinity Total Cholesterol reagent (Thermo Fisher Scientific, Wilmington, MA).
Results
lop13 phenotype
Clinical evaluation of lop13 eyes at postnatal day 28 (P28) confirmed the presence of bilateral nuclear cataracts (data not shown) as previously reported for lop13 mice (Varnum 1981) . Between 4 and 10 weeks of age, the lop13 nuclear cataracts progressed to mature cataracts (Fig. 1b) ; by 3 months of age, all lop13 mice exhibited hypermature cataracts (data not shown). The histological analysis of lop13 lenses confirmed the clinical findings. Lens epithelial cells at the anterior of the lens were normal (data not shown). Within the lens cortex and at the lens posterior (Fig. 1d, f) , abnormalities of the lens fiber cells, such as swollen cortical fibers and bladder cells (Cogan 1962) , were noted. Liquefied lens material and proteinaceous morgagnian globules (Cogan 1962 ) associated with the degeneration of lens fibers were also present at the posterior poles (Fig. 1f) .
In addition to the cataract phenotype, lop13 mice developed persistent wounds of the skin at around 3 months of age. The wounds were observed in the areas surrounding the eye (Fig. 2b) and the skin on the back of the neck (not shown). Once wounds developed, they did not heal. Histological analysis of lop13 skin, prior to the wound formation, did not identify any difference in the skin morphology between wild-type and lop13 mice (Fig. 2c, d ).
Genetic mapping of the lop13 locus An earlier report established linkage of the lop13 locus to mouse Chr 15 without any additional information regarding the genetic position of lop13 on Chr 15 (Chang et al. 2005) . To further map the lop13 locus, we generated 326 F2 backcross progeny that were clinically evaluated for cataracts. The analysis identified 46.3% (151/326) of the mice affected with cataracts and 53.7% (175/326) of the mice with clinically normal lenses. The v 2 analysis confirmed that the expected Mendelian ratios were observed. To confirm linkage to Chr 15, we initially genotyped 25 F2 progeny with 12 polymorphic microsatellites spread across Chr 15. The analysis confirmed linkage of the lop13 locus to Chr 15 (LOD [ 10) and assigned lop13 between microsatellites D15Mit29 and D15Mit161 (data not shown). We genotyped an additional 119 F2 backcross mice with microsatellite markers between D15Mit29 and D15Mit161. The analysis mapped the lop13 locus between microsatellites D15Mit118 and D15Mit33 (Fig. 3a) . An additional 182 F2 progeny were genotyped with D15Mit118 and D15Mit33, which led to the identification of three more recombinant animals between these two microsatellites (data not shown). To further map the chromosomal break points in the five recombinant animals, we searched for additional polymorphic markers within the genomic region between D15Mit118 and D15Mit33. However, no other microsatellites polymorphic between C3A.BLiA-Pde6b?/J and 129/sv-ter were identified. The SNP database analysis (http://www.ncbi.nlm.nih.gov/SNP/ MouseSNP.cgi) identified rs8248376 and rs4230909 as polymorphic SNPs within the genomic region between Fig. 1 Cataracts in lop13 mice. At 8 weeks of age wild-type mice exhibit clear lenses (a) in contrast to total cataracts observed in lop13 eyes (b). Histological analysis of lens sections from wild-type lenses (c) revealed highly organized fiber cells while swollen fiber cells (arrow) and bladder cells (arrowhead) were identified in lop13 lenses (d). At the posterior of the lop13 lenses (f) morgagnian globules and liquefied lens material (asterisk) were noted. Clear and organized lens structures were observed in wild-type lenses (e) Fig. 2 Skin phenotype in lop13 mice. Around 3 months of age lop13 mice (b) develop persistent wounds of the skin surrounding the eyes that were not present in heterozygote littermates (a). Histological analysis of skin sections from the back of the neck did not reveal any differences in skin morphology between wild-type (c) and lop13 (d) prior to onset of a wound D15Mit118 and D15Mit33. However, rs8248376 and rs4230909 were not informative in our cross (data not shown), precluding further mapping of the chromosomal break points with established markers.
The evaluation of the mouse genome (Build 37/mm9 assembly) established that the physical distance between D15Mit118 and D15Mit33 is 1.8 Mb (Fig. 3c) , encompassing 29 candidate genes (http://genome.ucsc.edu/cgibin/hgGateway). We evaluated the NCBI (http://www. ncbi.nlm.nih.gov/gene/) and MGI databases (http://www. informatics.jax.org/) to identify if any genes from the lop13 critical region were associated with cataracts and/or skin phenotypes in humans or mice. None of the candidate genes within this region had been previously identified as being associated with cataract formation or as playing a role in the development or homeostasis of the lens and skin. Thus, we initiated sequencing of the 29 candidate genes. Our sequence analysis of the Csdc2 gene identified a SNP, termed ss325997172, that exhibited polymorphisms between the C3A.BLiA-Pde6b?/J strain (''C'' allele) and the 129/sv-ter strain (''A'' allele) in this locus (Fig. 3b) . In the C3A.BLiA-Pde6b?/J strain, ss325997172 results in a nonsynonymous substitution of L7S, whereas the sequence from lop13 mice matched the Csdc2 (NM_145473) reference sequence. Similarly, our sequence analysis identified a SNP in the 5 0 UTR region of the Serhl gene (nucleotide 82930685), termed ss325997173, that showed polymorphism between the C3A.BLiA-Pde6b?/J (''G'' allele) and the 129/sv-ter strain genotyped (''C'' allele) in this locus. These two novel informative SNPs between the C3A.BLiA-Pde6b?/J and the 129/sv-ter strains provided an opportunity to further narrow down the lop13 candidate Fig. 3 Genetic analysis of the lop13 locus. a The lop13 locus was mapped between D15Mit118 and D15Mit33 to a 1.8 Mb region on Chr 15. (Black boxes = C3A.BliAPde6b?/J alleles and white boxes = 129/sv-ter alleles.) b Two novel informative SNPs identified in Csdc2 and Serhl genes were designated ss325997172 and ss325997173 respectively. c ss325997172 and ss325997173 allowed for further mapping of the chromosomal breakpoints in two backcross recombinants that narrowed down the lop13 critical region to 1.1 Mb region. The chromosomal break points from the two recombinants established the lop13 critical region as being between ss325997172 and ss325997173 (data not shown), a region of 1.1 Mb (Fig. 3c) Sequence analysis identified a C3112T substitution in exon 18 of Srebf2 (Fig. 4a) . Srebf2 was reported to be a ubiquitously expressed transcription factor in embryonic and adult tissues (Miserez et al. 1997) , although expression of Srebf2 was never evaluated in the lens. RT-PCR analysis revealed expression of Srebf2 in the embryonic and postnatal lens (Fig. 4b) . Thus, we proceeded with further evaluation of Srebf2 as a candidate gene. All affected lop13 mice exhibited the presence of the ''T'' allele at Srebf2 nucleotide 3112. This mutation results in an R1038C substitution within the regulatory domain of the Srebf2 protein (Fig. 4c) . The R1038 amino acid is highly conserved, suggesting an imperative function across different species (Fig. 4d) . To evaluate whether the R1038C substitution was potentially a rare polymorphism, the mouse SNP database was evaluated (http://www.ncbi.nlm.nih.gov/ SNP/snp_ref.cgi?locusId=20788). No SNPs were identified in Srebf2 exon 18. In addition, the genotype of the Srebf2 C3112 locus was independently evaluated in the C57BL/6J, C3H/HeJ, CAST/EiJ, RIIIS/J, and DBA/2J strains. All strains exhibited the presence of the ''C'' allele at Srebf2 nucleotide 3112, indicating that R1038 was Fig. 4 The evaluation of Srebf2 as a lop13 candidate gene. a Chromatograms depict a wildtype C/C, a heterozygote C/T and a lop13 T/T alleles of Srebf2; the arrow points to the nucleotide 3112 of Srebpf2 ORF. b RT-PCR analysis of Srebf2 using total RNA from embryonic (E) and postnatal (P) lenses (top panel 
Complementation studies
To provide genetic evidence that the disease-causing mutation in lop13 mice was in the Srebf2 gene, we initiated complementation studies. Srebf2 knockout mice die between E7 and E8 (Horton et al. 2002) . The Srebf2 genetrap.org/cgi-bin/annotation.py?cellline=YTA054). We set out to determine the precise genomic location of the pGT0Lxf gene trap insertion. LR-PCR analysis identified pGT0Lxf trap presence following nucleotide 81994703 in Srebf2 intron 1 (Fig. 5b) . RT-PCR analysis of Srebf2 GT/? mice confirmed the presence of the fused Srebf2 GT transcript (Fig. 5d) . The Srebf2 GT/? mice were clinically evaluated for cataracts and did not differ from wild-type mice (data now shown). In order to obtain Srebf2 GT/GT mice, we set up Srebf2 GT/? 9 Srebf2 GT/? breedings and generated 51 mice from nine different litters. Genotyping of the progeny at P0.5 identified 15 Srebf2
?/? and 36 Srebf2 GT/? mice, with the absence of any Srebf2 GT/GT mice suggesting embryonic lethality of Srebf2 GT/GT mice. Thus, for complementation studies we set up Srebf2 GT/? 9 lop13/lop13 breedings. This cross-generated 37 mice from 12 litters. We clinically evaluated all complementation progeny. At 6 weeks of age, 12 of 37 mice exhibited cataracts similar to the cataracts observed in lop13 mice (Fig. 6b ) and 25 of 37 had normal lenses (Fig. 6a) . Genotyping revealed that all mice exhibiting cataracts were compound heterozygote Srebf2 lop13/GT and that animals that were clinically normal genotyped as Srebf2 lop13/? . The v 2 analysis identified deviation from the expected Mendelian segregation (p \ 0.05), suggesting embryonic lethality of some Srebf2 lop13/GT animals. Histological analysis confirmed the presence of cataracts in Srebf2 lop13/GT mice with the presence of swollen fibers and bladder cells at the cortex and liquefied lens material and morgagnian globules at the lens posterior (Fig. 6d, f) , similar in appearance to the cataract phenotype observed in lop13 lenses. The Srebf2 lop13/GT mice also developed persistent wounds of the skin surrounding the eyes and the back of the neck, as observed in the lop13 mice (data not shown). The lack of complementation in compound heterozygote Srebf2 lop13/GT mice indicates that the C3112T substitution in Srebf2 is the mutation responsible for the lop13 phenotype.
Cholesterol analysis
We next examined whether the Srebf2 C3112T mutation altered cholesterol levels in lop13 tissues. Lipids from the brain, liver, and lenses were extracted from lop13 and wildtype mice and the cholesterol levels were analyzed by gas chromatography. A significant decrease in cholesterol levels was observed in the lop13 brain compared to the wild-type brain (p \ 0.05), with the lop13 brain containing an average of 219.25 (±34.3) lmol cholesterol/g lipid and the wild-type brain containing 368.6 (±49) lmol cholesterol/g lipid (Fig. 7a) . The average level of cholesterol in the lop13 liver was 24.4 (±5.6) lmol cholesterol/g lipid and that in the wild-type liver was 91.9 (±16.5) lmol cholesterol/g lipid, resulting in a significant decrease of GT allele. The chromatogram depicts the pGT0Lxf vector sequence following nucleotide 81994703 in the Srebf2 intron 1 (b) that is not present in the Srebf2 intron 1 in wild-type mice (a). The Srebf2 cDNA sequence from a wild-type mouse exhibits proper splicing of exons 1 and 2 (c) The cDNA sequence analysis from a Srebf2 GT/? mouse identified splicing between Srebf2 exon 1 and the b-geo coding sequence from pGT0Lxf indicating presence of the non-functioning fused Srebf2
GT allele cholesterol in the lop13 liver (p \ 0.005) (Fig. 7b) . A significant decrease (p \ 0.05) in cholesterol levels was also observed in the lop13 lens which contained an average of 1.6 (±0.19) lmol cholesterol/g lipid compared to the wild-type lens which contained 3.2 (±0.43) lmol cholesterol/g lipid (Fig. 7c) . In contrast, there was no difference in serum cholesterol levels between the wild-type and lop13 mice (Fig. 7d) .
Discussion
In this study we identified a C3112T mutation in Srebf2 exon 18 as being responsible for the lop13 phenotype. Srebf2 belongs to a family of membrane-bound basic helixloop-helix leucine zipper transcription factors that control the expression of genes involved in the biosynthesis and uptake of cholesterol and fatty acids (Ikonen 2008; Rawson 2003) . When cholesterol is abundant within a cell, the Srebf2 precursor resides in the endoplasmic reticulum (ER) membrane bound to SREBF chaperone (Scap) via the regulatory domain (Goldstein et al. 2006; Ikonen 2008) . Cellular cholesterol binds to Scap, altering its conformation so that the insulin-induced gene (Insig) binds to the Scap/ Srebf2 complex and retains the complex in the ER (Ikonen 2008; Radhakrishnan et al. 2007 ). In the absence of cholesterol within the cell, the lack of cholesterol binding to Scap renders the protein incapable of binding to Insig (Sun et al. 2007 ). The Scap/Srebf complex is no longer retained in the ER and gets translocated to the golgi where site-1 and site-2 proteases cleave the hydrophobic loop of Srebf2, releasing the transcriptionally active N-terminal fragment to be transported to the nucleus (Goldstein et al. 2006; Ikonen 2008) . The N-terminal Srebf2 fragment can then bind to an E-box inverted DNA repeat (5 0 -CANNTG-3 0 ) sequence and to the direct DNA repeat of the sterol-binding element (SRE) (5 0 -TCACNCCAC-3 0 ) (Ikonen 2008; Raghow et al. 2008 ). In mice, a null allele of the Srebf2 gene results in embryonic lethality (Horton et al. 2002) , indicating an essential role of Srebf2 in embryogenesis. In humans, polymorphisms in SREBP2 have been identified as being associated with polygenic and familial hypercholesterolemia (Duan et al. 2005; Miserez et al. 2002; Muller and Miserez 2002) . A mutation in SREBF2 in a mutant CHO cell line was identified that resulted in a truncated gene product and resistance to transcriptional repression by 25-hydroxycholesterol. Consequently, the mutation resulted in the constitutive transactivation of SREBF2 targets, independent of levels of sterols within the cell (Yang et al. 1994) . These studies collectively suggest that mutations in Srebf2 can result in a spectrum of phenotypes depending on the degree to which Srebf2 transcriptional activity is affected and ultimately the levels of cholesterol within the cell.
The Srebf2 C3112T mutation identified in lop13 mice results in a R1038C substitution of an evolutionarily conserved arginine residue within the Srebf2 regulatory domain. Our results showed significantly reduced levels of cholesterol in lop13 brains, livers, and lenses. Our hypothesis is that R1038C alters the Srebf2 regulatory domain's ability to efficiently interact with Scap and consequently reduces the levels of the Srebf2 precursor that is translocated to the golgi. Alternatively, the R1038C substitution might result in a conformational change of Srebf2 that compromises the efficacy of site 1 or site 2 or both proteases. These mechanisms would alter the levels of the transcriptionally active Srebf2 N-terminal fragment in the nucleus and result in reduced transactivation of Srebf2 downstream targets. This is further supported by our results showing that the levels of circulating cholesterol in lop13 mice did not differ from that in wild-type mice. Srebf2 is the principal transcriptional regulator of genes essential for cholesterol synthesis and endocytic cholesterol uptake (Ikonen 2008; Raghow et al. 2008) . Thus, Srebf R1038C hypomorphic function would consequently decrease both the rate of de novo cholesterol synthesis and the rate of endocytic cholesterol uptake.
In humans, mutations in 7 of 25 genes involved in the endogenous cholesterol synthesis pathway result in clinically distinct metabolic malformation syndromes. These syndromes include varying abnormalities of the brain, face, . A significant decrease in cholesterol levels was also observed in the lop13 lens containing an average of 1.6 (±0.19) lmol of cholesterol/g of lipid compared to the wild-type brain containing 3.2 (±0.43) lmol of cholesterol/g of lipid (c). There was no difference between serum cholesterol levels of the male and female lop13 and wild-type mice. (*p-value \ 0.05, **p-value \ 0.01) lens, lung, heart, liver, skeleton, and skin (Herman 2003; Kelley and Herman 2001; Nwokoro et al. 2001) . Cataracts and skin abnormalities were observed in some patients affected with metabolic malformation syndromes (Herman 2003; Kelley and Herman 2001) . The mechanisms by which mutations in different genes of the cholesterol synthesis pathway have resulted in variable and overlapping phenotypes have not yet been elucidated. It has been hypothesized that the accumulation of various sterol precursors, in addition to the deficiency of cholesterol, might result in the disruption of normal development (Nwokoro et al. 2001) . The variation in clinical phenotypes might be dependent upon the specific precursor from the cholesterol synthesis pathway that is accumulating. However, the reduction of tissue cholesterol without the accumulation of cholesterol precursors has been associated with cataracts in Shumiya rats (Mori et al. 2006) . These rats carry hypomorphic mutations in lanosterol synthase and farnesyl diphosphate farnesyl transferase 1, resulting in 57% of the cholesterol levels detected in wild-type lenses (Mori et al. 2006) . The results from our study also show that reduced levels of cholesterol in lop13 tissues play a role in the cataract and skin phenotype. However, we have not yet investigated whether cholesterol precursors may also be accumulating in lop13 tissues and therefore participating in the formation of cataracts and skin abnormalities observed in lop13 mice.
Although basal skin cells are capable of endocytic cholesterol uptake from circulation, most of the cholesterol in the epidermis is synthesized via de novo synthesis (Feingold 2009 ). The adult ocular lens is nonvascularized and fulfills its cholesterol needs solely via de novo synthesis (Cenedella 1983) . These findings suggest an essential role of de novo cholesterol synthesis for the normal function of the lens and skin. This is further supported by studies where treatments of animals with some pharmacological agents that inhibit enzymes from the cholesterol synthesis pathway resulted in cataracts and defects in the barrier function of the skin (Cenedella 1996; Feingold 2009 ). Therefore, hypomorphic Srebf R1038C function likely causes the lop13 cataracts and skin wounds due to a decreased rate of de novo cholesterol synthesis. However, the precise role of de novo cholesterol synthesis in these tissues remains unknown. In the lens, almost all of the cholesterol is confined to the lens fiber cell plasma membranes. These membranes are unusual as they contain the highest molar ratio of cholesterol to phospholipid of any known membrane (Li et al. 1985) . Defects in the structure of lop13 lens fiber cells further support an essential role of cholesterol for the lens fiber cells. In the skin, cholesterol is a major lipid class in the stratum corneum that serves as the principal barrier against chemical, microbial, and mechanical forces. The absence of any cellular defects in lop13 skin prior to wound formation suggests that cholesterol may be critical for wound repair. In addition, the expression of Srebf2 and the rate of epidermal cholesterol synthesis are increased during repair of the permeability barrier of the skin (Feingold 2009 ). Future studies of animal models with cholesterol biosynthesis defects will likely yield insight into the specific mechanism(s) in which cholesterol is imperative in these tissues. The lop13 mouse is an excellent resource for evaluating the role of Srebf2 and de novo cholesterol synthesis in maintaining the homeostasis of the lens and skin.
